Waagsbø B - Search Results

1

Low levels of short- and medium-chain acylcarnitines in HIV-infected patients.

Waagsbø B, Svardal A, Ueland T, Landrø L, Øktedalen O, Berge RK, Flo TH, Aukrust P, Damås JK. Waagsbø B, et al. Eur J Clin Invest. 2016 May;46(5):408-17. doi: 10.1111/eci.12609. Epub 2016 Mar 7. Eur J Clin Invest. 2016. PMID: 26913383

2

High levels of discordant antimicrobial therapy in hospital-acquired bloodstream infections is associated with increased mortality in an intensive care, low antimicrobial resistance setting.

Waagsbø B, Stuve N, Afset JE, Klepstad P, Mo S, Heggelund L, Damås JK. Waagsbø B, et al. Infect Dis (Lond). 2022 Oct;54(10):738-747. doi: 10.1080/23744235.2022.2083672. Epub 2022 Jun 16. Infect Dis (Lond). 2022. PMID: 35708021

3

Antimicrobial therapy of community-acquired pneumonia during stewardship efforts and a coronavirus pandemic: an observational study.

Waagsbø B, Tranung M, Damås JK, Heggelund L. Waagsbø B, et al. BMC Pulm Med. 2022 Oct 14;22(1):379. doi: 10.1186/s12890-022-02178-6. BMC Pulm Med. 2022. PMID: 36242006 Free PMC article.

4

Empirical antimicrobial therapy for bloodstream infections not compliant with guideline was associated with discordant therapy, which predicted poorer outcome even in a low resistance environment.

Grøv K, Håland E, Waagsbø B, Salvesen Ø, Damås JK, Afset JE. Grøv K, et al. Among authors: waagsbo b. Infect Dis (Lond). 2022 Dec;54(12):833-845. doi: 10.1080/23744235.2022.2109208. Epub 2022 Aug 9. Infect Dis (Lond). 2022. PMID: 35943909

5

Diagnostic stewardship aiming at expectorated or induced sputum promotes microbial diagnosis in community-acquired pneumonia.

Waagsbø B, Buset EM, Longva JÅ, Bjerke M, Bakkene B, Ertesvåg AS, Holmen H, Nikodojevic M, Tran TT, Christensen A, Nilsen E, Damås JK, Heggelund L. Waagsbø B, et al. BMC Infect Dis. 2022 Mar 2;22(1):203. doi: 10.1186/s12879-022-07199-4. BMC Infect Dis. 2022. PMID: 35236305 Free PMC article.

6

Climate and influenza in Oslo: A case for vapour pressure.

Kolberg ES, Tranung M, Sundell N, Waagsbø B. Kolberg ES, et al. Among authors: waagsbo b. J Clin Virol. 2019 Aug;117:54-55. doi: 10.1016/j.jcv.2019.06.002. Epub 2019 Jun 10. J Clin Virol. 2019. PMID: 31207548 No abstract available.

7

Reduction of unnecessary i.v. antibiotic days using general criteria for antibiotic switch.

Waagsbø B, Sundøy A, Paulsen EQ. Waagsbø B, et al. Scand J Infect Dis. 2008;40(6-7):468-73. doi: 10.1080/00365540701837134. Scand J Infect Dis. 2008. PMID: 18584533

8

Treatment results with debridement and retention of infected hip prostheses.

Waagsbø B, Sundøy A, Martinsen TM, Nymo LS. Waagsbø B, et al. Scand J Infect Dis. 2009;41(8):563-8. doi: 10.1080/00365540902984719. Scand J Infect Dis. 2009. PMID: 19452351

9

[Young girl with abscesses in the face].

Waagsbø B, Tofteland S, Kittang OB. Waagsbø B, et al. Tidsskr Nor Laegeforen. 2011 Nov 15;131(22):2246-8. doi: 10.4045/tidsskr.09.1237. Tidsskr Nor Laegeforen. 2011. PMID: 22085952 Free article. Norwegian.

10

Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea.

Garborg K, Waagsbø B, Stallemo A, Matre J, Sundøy A. Garborg K, et al. Among authors: waagsbo b. Scand J Infect Dis. 2010 Dec;42(11-12):857-61. doi: 10.3109/00365548.2010.499541. Epub 2010 Jul 22. Scand J Infect Dis. 2010. PMID: 20662620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page